Loading the section
Closing prices for September 18, 2026
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 18, 2026 | 8.46 | 8.53 | 8.20 | 8.48 | 18m |
| September 17, 2026 | 8.14 | 8.80 | 8.12 | 8.46 | 19m |
| September 16, 2026 | 8.14 | 8.30 | 7.76 | 7.91 | 9m |
| September 15, 2026 | 8.32 | 8.34 |
Based on reports through December 31, 2025
No events for this security recently.
ImmunityBio, Inc. (IBRX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 113.3m $, net income was -351.4m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121, US
| 359m |
| HALOHalozyme Therapeutics, Inc. | 112.45 | +2.53 % | 245m |
| TWSTTwist Bioscience Corporation | 163.47 | +5.08 % | 226m |
| TECHBio-Techne Corp | 72.38 | −0.05 % | 192m |
| NBIXNeurocrine Biosciences, Inc. | 146.23 | −3.69 % | 178m |
| 7.85 |
| 8.14 |
| 9m |
| September 14, 2026 | 7.89 | 8.40 | 7.87 | 8.37 | 9m |
| September 11, 2026 | 7.80 | 8.35 | 7.80 | 7.91 | 12m |
| September 10, 2026 | 7.87 | 7.89 | 7.64 | 7.72 | 9m |
| September 09, 2026 | 8.22 | 8.36 | 7.88 | 8.06 | 9m |
| September 08, 2026 | 8.00 | 8.37 | 7.93 | 8.29 | 8m |
| September 04, 2026 | 8.08 | 8.24 | 8.01 | 8.08 | 4m |
| September 03, 2026 | 8.00 | 8.21 | 7.88 | 8.19 | 5m |
| September 02, 2026 | 7.95 | 8.28 | 7.76 | 7.95 | 7m |
| September 01, 2026 | 7.82 | 7.99 | 7.73 | 7.87 | 6m |
| August 31, 2026 | 7.88 | 8.02 | 7.84 | 7.95 | 7m |
| August 28, 2026 | 8.31 | 8.32 | 7.95 | 8.05 | 8m |
| August 27, 2026 | 8.24 | 8.76 | 8.18 | 8.40 | 12m |
| August 26, 2026 | 8.17 | 8.40 | 8.07 | 8.25 | 9m |
| August 25, 2026 | 7.69 | 8.23 | 7.68 | 8.19 | 12m |
| August 24, 2026 | 7.68 | 7.72 | 7.46 | 7.58 | 6m |
| August 21, 2026 | 7.85 | 7.95 | 7.60 | 7.79 | 8m |